Medirom Healthcare Technologies INC. (MRM) — SEC Filings

Overview

Medirom Healthcare Technologies INC. (MRM) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 29, 2025: On December 29, 2025, Medirom Healthcare Technologies Inc. announced it has entered into a Master Service Agreement with Tools For Humanity and the World Foundation. The MEDIROM Group will be responsible for providing services under this agreement.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 47 neutral. The dominant filing sentiment for Medirom Healthcare Technologies INC. is neutral.

Filing Type Overview

Medirom Healthcare Technologies INC. (MRM) has filed 48 6-K, 1 20-F, 1 SC 13G with the SEC between Sep 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (50)

• Medirom Healthcare Signs Master Service Agreement — 6-K · Dec 29, 2025 Risk: low
  On December 29, 2025, Medirom Healthcare Technologies Inc. announced it has entered into a Master Service Agreement with Tools For Humanity and the World Founda
• Medirom Healthcare Reports November 2025 KPIs — 6-K · Dec 22, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for November 2025 on December 22, 2025. The company, based in Tokyo, Japan,
• Medirom Healthcare Closes JPY400M Convertible Bond Sale — 6-K · Dec 15, 2025 Risk: medium
  On December 12, 2025, Medirom Healthcare Technologies Inc. completed the sale and issuance of JPY400,000,000 in unsecured convertible bonds with share options t
• Medirom Healthcare Issues Convertible Bonds Worth ¥400M — 6-K · Dec 12, 2025 Risk: medium
  On December 11, 2025, Medirom Healthcare Technologies Inc. announced the issuance of its Third Unsecured Convertible-Type Corporate Bonds with Share Options. Th
• 6-K Filing — 6-K · Dec 4, 2025
• 6-K Filing — 6-K · Dec 3, 2025
• Medirom Subsidiary Completes Series A Financing — 6-K · Oct 30, 2025 Risk: medium
  On October 30, 2025, Medirom Healthcare Technologies Inc. announced the completion of a Series A equity financing round for its subsidiary, MEDIROM MOTHER Labs
• Medirom Healthcare Adopts Cryptocurrency for Treasury — 6-K · Oct 29, 2025 Risk: medium
  On October 29, 2025, Medirom Healthcare Technologies Inc. announced that its Board of Directors has approved the adoption of cryptocurrency as part of its treas
• Medirom Hits 10,000 Verifications Milestone — 6-K · Oct 28, 2025 Risk: low
  On October 28, 2025, Medirom Healthcare Technologies Inc. announced it has surpassed 10,000 verifications using a new technological device at its wellness salon
• Medirom Healthcare Files 6-K with Q2 2025 Financial Data — 6-K · Oct 21, 2025 Risk: low
  Medirom Healthcare Technologies Inc. filed a 6-K report for the period ending June 30, 2025. The filing includes financial data such as Additional Paid-In Capit
• Medirom Healthcare Releases September 2025 KPIs — 6-K · Oct 20, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its updated Key Performance Indicators (KPIs) for September 2025 via a press release issued on October 20, 2025.
• Medirom Subsidiary Completes Series A Equity Financing — 6-K · Oct 9, 2025 Risk: medium
  Medirom Healthcare Technologies Inc. announced on October 9, 2025, that its subsidiary, MEDIROM MOTHER Labs Inc., has successfully completed a Series A equity f
• Medirom Expands Salon Network with New Tech — 6-K · Sep 25, 2025 Risk: low
  On September 25, 2025, Medirom Healthcare Technologies Inc. announced the expansion of its relaxation salon network by equipping more locations with a new techn
• Medirom Healthcare Reports August 2025 KPIs — 6-K · Sep 24, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for August 2025 in a press release dated September 24, 2025. The filing is
• Medirom's REMONY System Adopted by Japan Ground Self-Defense Force — 6-K · Sep 18, 2025 Risk: medium
  On September 18, 2025, Medirom Healthcare Technologies Inc. announced that the Japan Ground Self-Defense Force (JGSDF) has adopted their remote health monitorin
• Medirom Subsidiary's Product Certified — 6-K · Aug 28, 2025 Risk: low
  On August 28, 2025, Medirom Healthcare Technologies Inc. announced that its subsidiary, MEDIROM MOTHER Labs Inc., received product certification. This certifica
• Medirom Healthcare Technologies to Launch New Device — 6-K · Aug 22, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced on August 22, 2025, the upcoming introduction of a new technological device at select relaxation salon locations.
• Medirom Healthcare Reports July 2025 KPIs — 6-K · Aug 20, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for July 2025 via a press release on August 20, 2025. The company, based in
• Medirom Healthcare to Launch New Tech Device — 6-K · Aug 1, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced on August 1, 2025, that it will introduce a new technological device at some of its relaxation salon locations. T
• Medirom Healthcare Reports June 2025 KPIs — 6-K · Jul 21, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for June 2025 in a press release dated July 21, 2025. The company, headquar
• Medirom Healthcare Technologies Inc. Approves Stock Options — 6-K · Jun 30, 2025 Risk: low
  On June 26, 2025, Medirom Healthcare Technologies Inc. announced its board of directors approved the issuance of stock options under its 2024 Equity Incentive C
• Medirom Healthcare Reports May 2025 KPIs — 6-K · Jun 20, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for May 2025 in a press release dated June 20, 2025. The company is providi
• Medirom Regains Nasdaq Bid Price Compliance — 6-K · Jun 5, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced on June 5, 2025, that it has regained compliance with Nasdaq's minimum bid price requirement. The company receive
• Medirom Healthcare Holds Annual Shareholder Meeting — 6-K · May 30, 2025 Risk: low
  Medirom Healthcare Technologies Inc. held its 25th Ordinary General Meeting of Shareholders on May 30, 2025, in Tokyo, Japan. The meeting, which began at 9:00 a
• Medirom Healthcare Reports April 2025 KPIs — 6-K · May 20, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for April 2025 via a press release dated May 20, 2025. This filing is a rep
• Medirom Healthcare Files 2024 Annual Report — 20-F · Apr 29, 2025 Risk: medium
  Medirom Healthcare Technologies Inc. filed its annual 20-F report for the fiscal year ending December 31, 2024. The filing details the company's financial posit
• Medirom Healthcare Reports March 2025 KPIs — 6-K · Apr 25, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for March 2025 on April 25, 2025. The company, based in Tokyo, Japan, is a
• Medirom Healthcare Announces Shareholder Meeting Details — 6-K · Apr 23, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced on April 18, 2025, the convocation of its Ordinary General Meeting of Shareholders for the fiscal year 2024. This
• Medirom Healthcare Reports February 2025 KPIs — 6-K · Mar 21, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for February 2025 via a press release dated March 22, 2025 (Japan Standard
• Medirom Healthcare Technologies Secures Loan Financing — 6-K · Mar 17, 2025 Risk: medium
  On March 17, 2025, Medirom Healthcare Technologies Inc. announced it has obtained loan financing. The press release detailing this financing was dated March 18,
• Medirom Subsidiary Completes Series A Equity Financing — 6-K · Mar 13, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced on March 13, 2025, that its subsidiary, MEDIROM MOTHER Labs Inc., has successfully completed a Series A equity fi
• Medirom Healthcare Receives Nasdaq Non-Compliance Notice — 6-K · Mar 4, 2025 Risk: medium
  On February 27, 2025, Medirom Healthcare Technologies Inc. received a notification letter from Nasdaq stating the company is not in compliance with the minimum
• Medirom Healthcare Technologies Inc. Reports January 2025 KPIs — 6-K · Feb 21, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for January 2025 via a press release dated February 21, 2025. The company,
• Medirom Healthcare Releases Preliminary 2024 Financials — 6-K · Feb 18, 2025 Risk: low
  Medirom Healthcare Technologies Inc. filed a Form 6-K on February 18, 2025, to announce its unaudited, preliminary financial results for the year ended December
• Medirom Healthcare Reports December 2024 KPIs — 6-K · Jan 29, 2025 Risk: low
  Medirom Healthcare Technologies Inc. announced its updated Key Performance Indicators (KPIs) for December 2024 via a press release issued on January 29, 2025 (E
• Medirom Healthcare Completes Offering, Boosts Capital — 6-K · Jan 21, 2025 Risk: low
  On January 21, 2025, Medirom Healthcare Technologies Inc. announced the completion of an offering and an increase in its registered corporate capital. The press
• Medirom Healthcare Fires Auditor TAAD LLP — 6-K · Dec 27, 2024 Risk: medium
  On December 24, 2024, Medirom Healthcare Technologies Inc. dismissed its independent registered public accounting firm, TAAD LLP. The company has not yet appoin
• Medirom Healthcare Reports November 2024 KPIs — 6-K · Dec 23, 2024 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for November 2024 on December 23, 2024. The company is a foreign private is
• Medirom Subsidiary Completes Series A Financing — 6-K · Dec 13, 2024 Risk: low
  Medirom Healthcare Technologies Inc. announced on December 13, 2024, that its subsidiary, MEDIROM MOTHER Labs Inc., has completed a Series A equity financing ro
• Medirom Healthcare Prices $10M Share Offering — 6-K · Dec 12, 2024 Risk: medium
  On December 9, 2024, Medirom Healthcare Technologies Inc. entered into an underwriting agreement with ThinkEquity LLC for a public offering of 2,860,000 common
• Medirom Subsidiary Completes Series A Equity Financing — 6-K · Dec 11, 2024 Risk: medium
  Medirom Healthcare Technologies Inc. announced on December 11, 2024, that its subsidiary, MEDIROM MOTHER Labs Inc., has completed a Series A equity financing ro
• SC 13G Filing — SC 13G · Dec 10, 2024
• Medirom Subsidiary Receives Orders for MOTHER Bracelet — 6-K · Dec 9, 2024 Risk: low
  On December 9, 2024, Medirom Healthcare Technologies Inc. announced through a Form 6-K filing that its subsidiary, MEDIROM MOTHER Labs Inc., has received orders
• Medirom Healthcare Technologies Inc. Subsidiary Secures Series A Funding — 6-K · Dec 6, 2024 Risk: medium
  On December 2, 2024, Medirom Healthcare Technologies Inc. announced that M3, Inc., or an affiliate, participated in the Series A equity financing round for its
• Medirom Healthcare Reports October 2024 KPIs — 6-K · Nov 21, 2024 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for October 2024 in a press release dated November 21, 2024. The company is
• Medirom Healthcare Files 6-K with Interim Financials — 6-K · Nov 8, 2024 Risk: low
  Medirom Healthcare Technologies Inc. filed a Form 6-K on November 8, 2024, to report its unaudited condensed consolidated financial statements as of June 30, 20
• Medirom Healthcare Reports September 2024 KPIs — 6-K · Oct 24, 2024 Risk: low
  Medirom Healthcare Technologies Inc. announced on October 24, 2024, its updated Key Performance Indicators (KPIs) for September 2024. The company is providing t
• Medirom Subsidiary Forms Alliance with Elematec Corp. — 6-K · Oct 15, 2024 Risk: low
  On October 15, 2024, Medirom Healthcare Technologies Inc. announced that its subsidiary, MEDIROM MOTHER Labs Inc. (MML), entered into a Capital and Business All
• Medirom Healthcare Issues Convertible Bonds — 6-K · Oct 11, 2024 Risk: medium
  On October 8, 2024, Medirom Healthcare Technologies Inc. entered into a Bond Purchase Agreement for the issuance of Second Unsecured Convertible-Type Corporate
• Medirom Healthcare Reports August 2024 KPIs — 6-K · Sep 24, 2024 Risk: low
  Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for August 2024 via a press release on September 24, 2024. The filing is a

Risk Profile

Risk Assessment: Of MRM's 47 recent filings, 0 were flagged as high-risk, 14 as medium-risk, and 33 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

• 11 investors

Top Tags

press-release (21) · kpi (9) · foreign-private-issuer (9) · financing (9) · subsidiary (8) · kpi-update (6) · technology (4) · operational-update (4) · convertible-bonds (3) · foreign-issuer (3)

Key Numbers

• Convertible Bonds Issued: JPY400.0M — Represents capital raised by Medirom Healthcare
• Convertible Bond Issuance: ¥400.0M — Aggregate principal amount raised by Medirom Healthcare Technologies Inc.
• Verifications: 10,000 — Milestone achieved with new technological device at wellness salons.
• Reporting Period End Date: 2025-06-30 — The filing covers financial data up to this date for Q2 2025.
• Filing Date: 2025-10-21 — The date the 6-K report was submitted to the SEC.
• Fiscal Year End: 2024-12-31 — The period covered by the financial statements in the 20-F filing.
• Prior Year End: 2023-12-31 — Comparative financial data provided for the previous fiscal year.
• Earlier Year End: 2022-12-31 — Comparative financial data provided for an earlier fiscal year.
• Gross Proceeds: $10.0M — Expected funds raised from the public offering before expenses.
• Shares Offered: 2,860,000 — The total number of common shares being sold in the public offering.

Related Companies

M3

Frequently Asked Questions